Journal of Vascular and Interventional Radiology
Volume 20, Issue 9 , Pages 1133-1140 , September 2009

Should Incidental Asymptomatic Angiographic Stenoses and Occlusions Be Treated in Patients with Peripheral Arterial Disease?

  • Aoife N. Keeling, FFRRCSI, MRCPI, MSc

      Affiliations

    • Department of Academic Radiology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
    • ,
  • Peter A. Naughton, FRCSI, MD

      Affiliations

    • Department of Vascular Surgery, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
    • ,
  • Karim Khalidi, MRCPI

      Affiliations

    • Department of Academic Radiology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
    • Department of Vascular Surgery, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
    • ,
  • Alaa S. Ayyoub, MD

      Affiliations

    • Department of Academic Radiology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
    • ,
  • Cathal K. Kelly, FRCSI

      Affiliations

    • Department of Vascular Surgery, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
    • ,
  • Austin L. Leahy, FRCSI

      Affiliations

    • Department of Vascular Surgery, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
    • ,
  • David J. Bouchier-Hayes, FRCSI

      Affiliations

    • Department of Vascular Surgery, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
    • ,
  • Thanos Athanasiou, PhD, FETCS

      Affiliations

    • Department of Biosurgery and Surgical Technology, Surgical Epidemiology and Quality Unit, Imperial College London, St. Mary's Hospital, London, United Kingdom
    • ,
  • Michael J. Lee, MSc, FRCPI, FFRRCSI, FRCR

      Affiliations

    • Department of Academic Radiology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland
    • Corresponding Author InformationAddress correspondence to M.J.L.

Received 13 October 2008 ,Revised 18 May 2009 ,Accepted 20 May 2009.

References 

  1. Ruckley CV. Claudication. Br Med J. 1986;292:970–971
  2. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–1324
  3. Hirsch AT. Treatment of peripheral arterial disease—extending “intervention” to “therapeutic choice.”. N Engl J Med. 2006;354:1944–1947
  4. Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996;25:1172–1181
  5. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease associations with the ankle brachial index and leg symptoms. JAMA. 2004;292:453–461
  6. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20:384–392
  7. Glaser R, Selzer F, Faxon DP, et al. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation. 2005;111:143–149
  8. McDermott MM, Guralnik JM, Ferrucci L, et al. Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication. Circulation. 2008;117:2484–2491
  9. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) (Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation). Circulation. 2006;113:e463–e654
  10. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(suppl 1):S1–S75
  11. Sacks D, Marinelli DL, Martin LG, Spies JB Society of Interventional Radiology Technology Assessment Committee. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol. 2003;14(suppl):S395–S404
  12. Sacks D, McClenny TE, Cardella JF, Lewis CA Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(suppl):S199–S202
  13. Ali A, Abu-Omar Y, Patel A, et al. Valve failure following homograft aortic valve replacement: does implantation technique have an effect?. Eur Heart J. 2008;29:1454–1462
  14. Coolong A, Baim DS, Kuntz RE, et al. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 2008;117:790–797
  15. Petronio AS, De Carlo M, Branchitta G, et al. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study. J Am Coll Cardiol. 2007;49:539–546
  16. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J, Harrington DP. Revascularization for femoropopliteal disease: a decision and cost-effectiveness analysis. JAMA. 1995;274:165–171
  17. Valentine RJ, Jackson MR, Modrall JG, McIntyre KE, Clagett GP. The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service. J Vasc Surg. 1999;30:436–444
  18. Vidula H, Tian L, Liu K, et al. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med. 2008;148:85–93
  19. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115–126
  20. Schillinger M, Exner M, Mlekusch W, et al. Vascular inflammation and percutaneous transluminal angioplasty of the femoro-popliteal artery: association with restenosis. Radiology. 2002;225:21–26
  21. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation. 1990;81:602–609
  22. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain: a meta-analysis. JAMA. 1995;274:975–980
  23. Kearney PM, Blackwell L, Collins R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis (Cholesterol Treatment Trialists' (CTT) Collaborators). Lancet. 2008;371:117–125
  24. Aung PP, Maxwell HG, Jepson RG, Price JF, Leng GC. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev. 2007;CD000123. Update of: Cochrane Database Syst Rev 2000:CD000123.
  25. Welten GM, Schouten O, Hoeks SE, et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol. 2008;51:1588–1596
  26. Mukherjee D, Lingam P, Chetcuti S, et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation. 2002;106:1909–1912
  27. Creasy TS, McMillan PJ, Fletcher EWL, Collin J, Morris PJ. Is percutaneous transluminal angioplasty better than exercise for claudication? (Preliminary results from a prospective randomised trial). Eur J Vasc Surg. 1990;4:135–140
  28. McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286:1599–1606
  29. Lusis AJ. Atherosclerosis. Nature. 2000;407:233–241
  30. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Mueller KM. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol. 2000;35:157–163
  31. Da Costa ML, Redmond P, Bouchier-Hayes DJ. The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases. Surgery. 1998;124:516–525
  32. Peek RM, Mohla S, DuBois RN. Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting. Cancer Res. 2005;65:8583–8586
  33. Versaci F, Gaspardone A, Tomai F, et al. Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study). J Am Coll Cardiol. 2002;40:1935–1942
  34. Kaski JC, Chester MR, Chen L, Katritsis D. Rapid angiographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology. Circulation. 1995;92:2058–2066
  35. Chen L, Chester MR, Crook R, Kaski JC. Differential progression of complex culprit stenoses in patients with stable and unstable angina pectoris. J Am Coll Cardiol. 1996;28:597–603
  36. Saw J, Bhatt DL, Moliterno DJ, et al. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol. 2006;48:1567–1572
  37. Lederle FA, Wilson SE, Johnson GR, et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002;346:1437–1444
  38. The United Kingdom Small Aneurysm Trial Participants. Long-term outcomes of small abdominal aortic aneurysms: long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med. 2002;346:1445–1452
  39. Zarins CK, Crabtree T, Arko FR, et al. Endovascular repair or surveillance of patients with small AAA. Eur J Vasc Endovasc Surg. 2005;29:496–503
  40. Prinssen M, Buskens E, Blankensteijn JD DREAM trial participants. Quality of life endovascular and open AAA repair: results of a randomized trial. Eur J Vasc Endovasc Surg. 2004;27:121–127
  41. Cao P CAESAR Trial Collaborators. Comparison of surveillance vs aortic endografting for small aneurysm repair (CAESAR) trial: study design and progress. Eur J Vasc Endovasc Surg. 2005;30:245–251

 None of the authors have identified a conflict of interest.

PII: S1051-0443(09)00588-0

doi: 10.1016/j.jvir.2009.05.035

Journal of Vascular and Interventional Radiology
Volume 20, Issue 9 , Pages 1133-1140 , September 2009

Article Tools

* Image Usage & Resolution